Complement in organ transplantation
Authors:
- 1 August 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 15 (4) , 486-491
Abstract
Purpose of review The aim of this review is to bring to attention the most recent advances made in understanding the role of complement components in both innate and adaptive immune responses in solid organ transplantation with emphasis on the kidney. Recent findings Alongside recent findings related to the role of anaphylatoxins in modulating adaptive immune responses, there has been a genomic study to assess the expression of inflammatory markers in kidney transplantation, showing significant involvement of some complement molecules in predicting graft function. Modulators of complement pathway activity such as decay accelerating factor (CD55) and CD59 have also been shown to have a role in graft rejection. Potential new therapeutic targets related to complement proteins are being investigated. Summary The mechanism of rejection in solid organ transplantation is influenced by the initial inflammatory response and subsequent adaptive allo-immune response, both of which have been shown to be affected by various complement components. Due to limitations of existing treatments, new approaches are needed to better control these responses to improve graft survival. Built on an expanding knowledge of complement involvement, targeted blocking of the effector complement molecules and modulating the expression of complement inhibitors has suggested potentially useful approaches for reducing the effect of inflammatory damage from cold ischaemia as well as reducing the activation of the adaptive immune system related to complement.Keywords
This publication has 38 references indexed in Scilit:
- C5a receptor‐deficient dendritic cells promote induction of Treg and Th17 cellsEuropean Journal of Immunology, 2010
- The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumabTherapeutics and Clinical Risk Management, 2009
- CD46‐induced human Treg enhance B‐cell responsesEuropean Journal of Immunology, 2009
- Combination of Peritubular C4d and Transplant Glomerulopathy Predicts Late Renal Allograft FailureJournal of the American Society of Nephrology, 2009
- The role of the anaphylatoxins in health and diseaseMolecular Immunology, 2009
- Expression of Complement Components Differs Between Kidney Allografts from Living and Deceased DonorsJournal of the American Society of Nephrology, 2009
- Upregulation of CD59: Potential Mechanism of Accommodation in a Large Animal ModelTransplantation, 2009
- Gene Silencing of Complement C5a Receptor Using siRNA for Preventing Ischemia/Reperfusion InjuryThe American Journal of Pathology, 2008
- Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survivalClinical and Experimental Immunology, 2008
- Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4+ T CellsImmunity, 2008